SLFN11 can sensitize tumor cells towards IFN-γ-mediated T cell killing
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
SLFN11 can sensitize tumor cells towards IFN-γ-mediated T cell killing
Authors
Keywords
T cells, DNA damage, Toxicity, Antigen presentation, Cell death, Cloning, Cell metabolism, Metabolic analysis
Journal
PLoS One
Volume 14, Issue 2, Pages e0212053
Publisher
Public Library of Science (PLoS)
Online
2019-02-13
DOI
10.1371/journal.pone.0212053
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Regulation and Function of the PD-L1 Checkpoint
- (2018) Chong Sun et al. IMMUNITY
- SLFN11 Blocks Stressed Replication Forks Independently of ATR
- (2018) Junko Murai et al. MOLECULAR CELL
- DKK2 imparts tumor immunity evasion through β-catenin-independent suppression of cytotoxic immune-cell activation
- (2018) Qian Xiao et al. NATURE MEDICINE
- A major chromatin regulator determines resistance of tumor cells to T cell–mediated killing
- (2018) Deng Pan et al. SCIENCE
- Cancer immunotherapy using checkpoint blockade
- (2018) Antoni Ribas et al. SCIENCE
- Genetic wiring maps of single-cell protein states reveal an off-switch for GPCR signalling
- (2017) Markus Brockmann et al. NATURE
- Identification of CMTM6 and CMTM4 as PD-L1 protein regulators
- (2017) Riccardo Mezzadra et al. NATURE
- Identification of essential genes for cancer immunotherapy
- (2017) Shashank J. Patel et al. NATURE
- In vivo CRISPR screening identifies Ptpn2 as a cancer immunotherapy target
- (2017) Robert T. Manguso et al. NATURE
- Loss of IFN-γ Pathway Genes in Tumor Cells as a Mechanism of Resistance to Anti-CTLA-4 Therapy
- (2016) Jianjun Gao et al. CELL
- Mutations Associated with Acquired Resistance to PD-1 Blockade in Melanoma
- (2016) Jesse M. Zaretsky et al. NEW ENGLAND JOURNAL OF MEDICINE
- Primary Resistance to PD-1 Blockade Mediated by JAK1/2 Mutations
- (2016) Daniel Sanghoon Shin et al. Cancer Discovery
- Resistance to PARP inhibitors by SLFN11 inactivation can be overcome by ATR inhibition
- (2016) Junko Murai et al. Oncotarget
- SLFN11 inhibits checkpoint maintenance and homologous recombination repair
- (2015) Y. Mu et al. EMBO REPORTS
- Adoptive cellular therapy: A race to the finish line
- (2015) Carl H. June et al. Science Translational Medicine
- Exploiting the curative potential of adoptive T-cell therapy for cancer
- (2013) Christian S. Hinrichs et al. IMMUNOLOGICAL REVIEWS
- The Schlafen Family of Proteins and Their Regulation by Interferons
- (2013) Evangelos Mavrommatis et al. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
- Deciphering the Glycosylome of Dystroglycanopathies Using Haploid Screens for Lassa Virus Entry
- (2013) L. T. Jae et al. SCIENCE
- Codon-usage-based inhibition of HIV protein synthesis by human schlafen 11
- (2012) Manqing Li et al. NATURE
- The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
- (2012) Jordi Barretina et al. NATURE
- Fluorescence-Based Phenotypic Selection Allows Forward Genetic Screens in Haploid Human Cells
- (2012) Lidia M. Duncan et al. PLoS One
- Putative DNA/RNA helicase Schlafen-11 (SLFN11) sensitizes cancer cells to DNA-damaging agents
- (2012) G. Zoppoli et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cytotoxic immunological synapses do not restrict the action of interferon- to antigenic target cells
- (2012) N. S. R. Sanderson et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Ebola virus entry requires the cholesterol transporter Niemann–Pick C1
- (2011) Jan E. Carette et al. NATURE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now